Maccura Biotechnology Co Ltd
SZSE:300463
Intrinsic Value
Maccura Biotechnology Co., Ltd. engages in the research, development, production, sale, and service of in vitro diagnostic products. [ Read More ]
The intrinsic value of one Maccura Biotechnology Co Ltd stock under the Base Case scenario is 11.54 CNY. Compared to the current market price of 12.54 CNY, Maccura Biotechnology Co Ltd is Overvalued by 8%.
Valuation Backtest
Maccura Biotechnology Co Ltd
Run backtest to discover the historical profit from buying and selling Maccura Biotechnology Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Maccura Biotechnology Co Ltd
Current Assets | 4.5B |
Cash & Short-Term Investments | 1.2B |
Receivables | 1.9B |
Other Current Assets | 1.4B |
Non-Current Assets | 3.8B |
Long-Term Investments | 225.6m |
PP&E | 2.8B |
Intangibles | 561.8m |
Other Non-Current Assets | 194.2m |
Current Liabilities | 1.2B |
Accounts Payable | 341.6m |
Accrued Liabilities | 43.7m |
Short-Term Debt | 368.8m |
Other Current Liabilities | 452.3m |
Non-Current Liabilities | 692.5m |
Long-Term Debt | 217.1m |
Other Non-Current Liabilities | 475.3m |
Earnings Waterfall
Maccura Biotechnology Co Ltd
Revenue
|
3B
CNY
|
Cost of Revenue
|
-1.3B
CNY
|
Gross Profit
|
1.7B
CNY
|
Operating Expenses
|
-1.2B
CNY
|
Operating Income
|
466.9m
CNY
|
Other Expenses
|
-90.9m
CNY
|
Net Income
|
376m
CNY
|
Free Cash Flow Analysis
Maccura Biotechnology Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Maccura Biotechnology Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Maccura Biotechnology Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Maccura Biotechnology Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Score
Maccura Biotechnology Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Maccura Biotechnology Co Ltd
According to Wall Street analysts, the average 1-year price target for Maccura Biotechnology Co Ltd is 18.88 CNY with a low forecast of 18.7 CNY and a high forecast of 19.44 CNY.
Shareholder Return
Price
Maccura Biotechnology Co Ltd
Average Annual Return | 7.1% |
Standard Deviation of Annual Returns | 51.16% |
Max Drawdown | -83% |
Market Capitalization | 7.6B CNY |
Shares Outstanding | 612 469 590 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Maccura Biotechnology Co., Ltd. engages in the research, development, production, sale, and service of in vitro diagnostic products. The company is headquartered in Chengdu, Sichuan and currently employs 2,901 full-time employees. The company went IPO on 2015-05-28. The firm provides hundreds of products which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.
Contact
IPO
Employees
Officers
The intrinsic value of one Maccura Biotechnology Co Ltd stock under the Base Case scenario is 11.54 CNY.
Compared to the current market price of 12.54 CNY, Maccura Biotechnology Co Ltd is Overvalued by 8%.